Jpmorgan Chase & CO Athersys, Inc Transaction History

Jpmorgan Chase & CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	BUY	$0.18 - $0.86 $155,065 - $740,868	861,475 Added 37.56%	3,155,103 $820,000
Q1 2022 May 11, 2022	SELL	$0.6 - $1.06 $105,450 - $186,296	-175,751 Reduced 7.12%	2,293,628 $1.39 Million
Q4 2021 Feb 10, 2022	SELL	$0.85 - $1.4 $478,874 - $788,734	-563,382 Reduced 18.58%	2,469,379 $2.23 Million
Q3 2021 Nov 12, 2021	BUY	$1.33 - $1.77 $4.03 Million - $5.37 Million	3,032,761 New	3,032,761 $4.03 Million

Ticker ATHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 305,110,016
Market Cap $3.05M
Description
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

Stay updated on Jpmorgan Chase & CO with notifications on news.